Pricing Log in Create free account

Quest Diagnostics Incorporated (DGX) vs Medpace Holdings, Inc. (MEDP)

Quest Diagnostics Incorporated and Medpace Holdings, Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $26.4B against $17.6B — 1.5× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.6× against 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 9.87%. Medpace Holdings, Inc. has the higher net margin (17.7% vs 9.15%) and the lower return on invested capital (0.00% vs 7.94%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 12 and Quest Diagnostics Incorporated on 10.

Valuation

Metric DGX MEDP Diagnostics & Research median
P/E 24.63 35.56 35.56
P/S 2.26 6.26 4.37
P/B 3.34 40.16 3.06
Price to free cash flow 19.34 24.66 35.76
EV/EBITDA 14.07 27.87 24.35
EV/Sales 2.69 6.12 5.51
Earnings yield 4.06% 2.81% (1.89%)
Free cash flow yield 5.17% 4.06% (0.15%)

Profitability

Metric DGX MEDP Diagnostics & Research median
Gross margin 33.11% 72.35% 50.89%
Operating margin 14.10% 20.97% (8.57%)
Net margin 9.15% 17.67% (6.37%)
Free cash flow margin 11.67% 25.40% 0.00%
Return on equity 14.03% 162.15% (2.92%)
Return on assets 6.43% 27.09% (6.71%)
Return on invested capital 7.94% 0.00% 0.00%

Growth

Metric DGX MEDP Diagnostics & Research median
Revenue growth (TTM) 9.87% 24.67% 7.69%
EPS growth (last fiscal year) 13.78% 20.98% 25.92%
Revenue growth, 5-year CAGR 3.18% 22.27% 7.40%
Net income growth, 5-year CAGR (7.06%) 25.50% 0.00%

Health

Metric DGX MEDP Diagnostics & Research median
Debt to equity 0.72 0.00 0.11
Current ratio 1.59 0.73 2.02
Net debt to EBITDA 2.47 (0.88) 0.70

Dividend

Metric DGX MEDP Diagnostics & Research median
Dividend yield 1.44% — 0.66%
Payout ratio 0.36 — 0.20

Size

Metric DGX MEDP Diagnostics & Research median
Market cap 26.40b 17.55b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack